4basebio PLCLSE: 4BB

4basebio: Holding(s) in Company

· Issued by 4basebio PLC via PR Newswire

Summary by 6ix AI

Aberdeen Group plc told 4BASEBIO PLC on November 11, 2026 that its voting rights in the company rose above the 5% reporting threshold on November 10, 2026, reaching 7.571253%, or 1,456,310 voting rights.

Key details

  • The increase came from participation in the Placing, a share sale, which completed on November 10, 2026.
  • The voting rights are held through abrdn Holdings Limited and abrdn Inc. The shares are managed by abrdn Inc. in multiple portfolios for underlying clients, who have delegated their voting power to it under investment management agreements.
  • The whole position is in shares. None of the voting rights are held through financial instruments such as options.

6ix AI wrote this summary from the release below and checked it against the release.

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BMCLYF79

Issuer Name

4BASEBIO PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Aberdeen Group plc

City of registered office (if applicable)

Edinburgh

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

5. Date on which the threshold was crossed or reached

10-Nov-2026

6. Date on which Issuer notified

11-Nov-2026

7. Total positions of person(s) subject to the notification obligation

.

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

7.571253

0.000000

7.571253

1,456,310

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BMCLYF79

1,456,310

7.571253

Sub Total 8.A

1,456,310

7.571253

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Aberdeen Group plc

Aberdeen Group plc

abrdn Holdings Limited

Aberdeen Group plc

abrdn Inc.

7.571253

0.000000

7.571253

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

If date does not apply, explain below

11. Additional Information

In reference to Section 9, the shares detailed are managed by the named discretionary investment management entity within multiple portfolios on behalf of underlying clients, based on investment management agreements whereby the client has delegated the exercise of the voting power to the referenced investment manager.

This disclosure also reflects the fact that the voting rights effectively held indirectly by the underlying intermediate holding company abrdn Holdings Limited ("aHL") and held by the underlying investment management entity abrdn Inc. ("aInc") increased above the 5% notifiable threshold due to the participation in the Placing which completed on 10 November 2026. aHL now effectively holds and aInc holds the delegated voting rights to 7.571253% of the shares in 4basebio PLC.

12. Date of Completion

11-Nov-2026

13. Place Of Completion

Edinburgh, United Kingdom


4basebio PLC on 6ix

Story so far

Earlier from 4basebio

All 4basebio news releases